An off-label prescription is when a doctor prescribes an FDA-approved medication for a purpose, dose, or method that the FDA hasn’t specifically reviewed and approved. This is surprisingly common: roughly 1 in 4 prescriptions in the United States are written for off-label uses. It’s legal, often effective, and in many cases represents standard medical practice for certain conditions.
What “Off-Label” Actually Means
Before a drug reaches the market, its manufacturer must prove to the FDA that it’s safe and effective for a specific use. That approved use becomes the drug’s “label,” a detailed document describing which conditions the drug treats, at what dose, and in what form. Off-label use happens when a doctor prescribes that same approved drug outside those specific boundaries.
The FDA defines three main ways a prescription can be off-label:
- Different condition: Using a drug approved for one disease to treat a completely different one, like prescribing a chemotherapy drug approved for one cancer type to treat another.
- Different dose: Prescribing a higher or lower dose than what the label specifies.
- Different form or route: Giving a drug as a liquid when it was approved only as a capsule, for example.
An important distinction: off-label doesn’t mean unapproved or dangerous. It simply means the FDA hasn’t formally evaluated the drug for that particular use. The drug itself has still passed FDA review for safety and effectiveness in at least one context.
Why Doctors Prescribe Off-Label
Doctors prescribe off-label because medical knowledge often moves faster than the FDA approval process. Getting a drug approved for a new use requires expensive clinical trials that can take years, and manufacturers don’t always pursue approval for every condition a drug turns out to help. This is especially true for older, generic drugs where there’s little financial incentive to fund new trials.
Federal law gives doctors this flexibility by design. The Food, Drug, and Cosmetic Act authorizes the FDA to regulate what manufacturers can sell and advertise, but it does not give the agency authority over how physicians practice medicine. Once a drug is on the market, a licensed doctor can prescribe it for any use they judge to be medically appropriate. Omission from the approved label doesn’t mean the FDA disapproves of that use. It just means the agency hasn’t reviewed it.
Common Examples
Some of the most familiar medications are routinely used off-label. Gabapentin, originally approved for seizures, is widely prescribed for fibromyalgia, neuropathic pain, restless leg syndrome, hot flashes, and even hiccups. Fluoxetine (Prozac), approved for depression and a handful of other psychiatric conditions, is used off-label for diabetic neuropathy, fibromyalgia, and hot flashes. Aspirin, primarily a pain reliever, is prescribed off-label for blood clot prevention in atrial fibrillation. Even diphenhydramine (Benadryl), an allergy medication, gets prescribed off-label for insomnia and chemotherapy-related nausea.
In many of these cases, the off-label use is so well established and supported by clinical evidence that it’s considered standard care, even without formal FDA approval for that specific purpose.
Off-Label Use in Children and Cancer Treatment
Two areas where off-label prescribing is especially prevalent are pediatrics and oncology. About 40% of medications prescribed to children are used off-label, with up to 47% in some U.S. studies. The most common reason is dosing: nearly half of pediatric off-label prescriptions involve a dose that’s higher or lower than what the label recommends, because labels are often based on adult data. Age restrictions and unapproved indications account for most of the rest.
In cancer treatment, the numbers are also significant. An analysis of nearly 166,000 U.S. cancer patients found that 18.6% received at least one off-label drug during their treatment. Broader reviews across multiple countries have found rates ranging from 13% to 71%, depending on the cancer type and treatment setting. This happens because cancer biology is complex, and drugs that work for one tumor type sometimes work for others with similar genetic profiles.
Safety: What the Evidence Shows
Off-label prescriptions do carry a somewhat higher risk of adverse reactions compared to on-label use. A large study published in JAMA Internal Medicine found that adverse drug events occurred at a rate of 19.7 per 10,000 person-months for off-label use, compared to 12.5 for on-label use. That translates to roughly a 44% higher relative risk.
But here’s the critical nuance: that increased risk was almost entirely concentrated in off-label uses that lacked strong scientific evidence. When off-label use was backed by solid research, the rate of adverse events was statistically the same as on-label use. In other words, the risk isn’t really about whether a use is on or off the label. It’s about whether good evidence supports that use.
Will Insurance Cover It?
Insurance coverage for off-label prescriptions varies. Private insurers set their own policies, and coverage often depends on whether the off-label use is supported by recognized medical references. Medicare, for its part, will cover off-label drug use if it qualifies as a “medically accepted indication,” meaning the use is supported by major drug reference databases that compile and evaluate clinical evidence. If your off-label prescription gets denied, your doctor can sometimes submit supporting literature or a letter of medical necessity to appeal the decision.
For widely established off-label uses, coverage is rarely an issue. For newer or less common off-label applications, you may need to work with your doctor’s office to get prior authorization.
Drug Companies Can’t Promote Off-Label Uses
While doctors are free to prescribe off-label, pharmaceutical companies face strict limits on promoting those uses. Federal regulations prohibit manufacturers from marketing drugs for purposes the FDA hasn’t approved. A company that promotes off-label uses can face warning letters, civil fines, product seizures, and even fraud prosecution under the False Claims Act if the promotion leads to improper billing of government insurance programs. Over the years, several major pharmaceutical companies have paid billions in settlements for illegal off-label marketing.
This creates an interesting asymmetry: your doctor can prescribe a drug for virtually any use based on their clinical judgment, but the company that made the drug cannot suggest that use to the doctor through advertising or sales representatives.
Should Your Doctor Tell You?
Most physicians prescribe off-label without explicitly telling patients the drug hasn’t been approved for that particular purpose. Whether they should is an active ethical debate. The American Medical Association’s principles of informed consent and shared decision making suggest that patients should generally understand what a treatment involves and why it’s being recommended. Withholding the off-label status of a prescription arguably conflicts with those principles.
If you want to know whether a prescription is off-label, ask your doctor directly. You can also check the drug’s prescribing information (available on the FDA website or in the package insert) to see which conditions and doses are formally approved. Knowing doesn’t necessarily mean you should refuse the medication. Many off-label uses are backed by strong evidence and represent the best available treatment. But understanding what’s behind your prescription helps you make a more informed choice about your care.